J&J Gives AIDS Drug Rights to Charity for Vaginal Ring
This article is for subscribers only.
Johnson & Johnson gave the rights to an experimental AIDS drug to a charity that’s testing the medicine in a vaginal ring to prevent HIV infection.
J&J gave the global rights to develop and market dapivirine to the International Partnership for Microbicides, a Silver Spring, Maryland-based organization that works on developing HIV prevention tools for women, IPM said today in a statement.